Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05790122
What this trial is testing

Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma

Who this might be right for
Carcinoma, Renal CellKidney Neoplasms
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 146
Large-scale testing (Phase 3)Study completedNCT00087022
What this trial is testing

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Heidelberg Pharma AG 864
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Not applicableLooking for participantsNCT06863857
What this trial is testing

Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

Who this might be right for
Renal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 50
Not applicableStudy completedNCT00684645
What this trial is testing

Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 186
Testing effectiveness (Phase 2)Study completedNCT03679767
What this trial is testing

INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Who this might be right for
Metastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more
Incyte Corporation 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667
What this trial is testing

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more
ImmunityBio, Inc. 40
Early research (Phase 1)Active Not RecruitingNCT03618381
What this trial is testing

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+13 more
Seattle Children's Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03172754
What this trial is testing

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fox Chase Cancer Center 98
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT00303862
What this trial is testing

AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT00537056
What this trial is testing

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

Who this might be right for
Kidney NeoplasmsCarcinoma, Renal CellKidney (Renal Cell) Cancer
Stanford University 17
Testing effectiveness (Phase 2)Ended earlyNCT00090870
What this trial is testing

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 10
Testing effectiveness (Phase 2)Study completedNCT04337970
What this trial is testing

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Who this might be right for
Kidney CancerRenal Cell CarcinomaUnresectable Renal Cell Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)UnknownNCT04134182
What this trial is testing

Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 8
Testing effectiveness (Phase 2)Study completedNCT01024205
What this trial is testing

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Barts and the London School of Medicine and Dentistry 43
Testing effectiveness (Phase 2)Temporarily pausedNCT00033956
What this trial is testing

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Who this might be right for
IL-2 Induced Hypotension
MetaPhore Pharmaceuticals 48
Not applicableStudy completedNCT00717743
What this trial is testing

T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)

Who this might be right for
Renal Cell Carcinoma
National University Hospital, Singapore
Early research (Phase 1)Ended earlyNCT03343613
What this trial is testing

LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Study completedNCT00618982
What this trial is testing

Sorafenib Dose Escalation in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 83
Next Page